Preonditioning for patients who will undergo esophaguscardiaresectio

Completed

• Conditions: cancer of the esophagus; esophageal cancer; 10017990; 10017991

• Registration Number: NL-OMON33604
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

patients (>18 year) with esophageal cancer who will undergo esophaguscardiaresction after neoadjuvant therapy

Exclusion Criteria

lack of informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Scores on the questionnaires, long function, muscle force measurements, BMI,<br /><br>handdynamometry. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Complications, hospital length of stay, re-admission and mortality. </p><br>